Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 45.55
-0.85 (-1.83%)
Sep 8, 2026, 1:30 PM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 5.48 billion as of September 4, 2026. Its market cap has decreased by -33.01% in one year.
Market Cap
5.48B
Enterprise Value
7.91B
Revenue
4.64B
Ranking
n/a
PE Ratio
11.63
Stock Price
45.55
ChartMarket Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has decreased from 5.60B to 5.48B, a decrease of -2.18%. That is a compound annual growth rate of -0.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 5.48B | -23.19% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 10.01B |
| SCI Pharmtech | 6.70B |
| Alar Pharmaceuticals | 6.14B |
| Orient Pharma | 6.12B |
| Panion & Bf Biotech | 4.83B |
| Yoda Pharmaceuticals | 4.57B |
| LIWANLI Innovation | 4.45B |
| Orient EuroPharma | 3.96B |